Invacare Corporation (NYSE:IVC) is pleased to announce that the company received 510(k) clearance from the FDA for the Invacare® TDX® SP2 Power Wheelchair with LiNX® Technology.
“This exciting milestone puts Invacare one step closer to introducing this power wheelchair which redefines the complex rehab category,” said Brian LaDuke, VP of Rehab Marketing at Invacare.
The revolutionary product is scheduled to launch mid-August in the United States and will be available for order at that time.
From its base to the cloud, the Invacare TDX SP2 Power Wheelchair delivers features and performance wheelchair clients and clinicians will love, along with reliability and rehab-redefining functionality providers will appreciate. The TDX SP2 Power Wheelchair is designed to be a go-to solution for a wide variety of rehab clients. Simply stated, the TDX SP2 Power Wheelchair is the new industry standard for complex rehab.
The first of its kind in the power wheelchair industry, the REM400 remote with touch screen display has the look and intuitive interaction of a smart device with thoughtful adaptations for power wheelchair users, allowing consumers to swipe or tap to interact as they would other consumer electronics.
Watch early reactions to the TDX SP2 Power Wheelchair with LiNX Technology here.
About Invacare Corporation
A global leader in manufacturing home medical devices, Invacare is dedicated to putting the patient at the center of everything we do. We are passionate about providing clinical solutions for post-acute care, rehab, homecare, and respiratory markets to promote our Corporate Vision—Making Life’s Experiences Possible™.